StellarQ Oy and Medino Oy have initiated a strategic collaboration project supported by an EU Regional Funding Program (ERFP). The one-year project will commence in January 2026 and supports StellarQ’s preparation for international expansion into the Nordic countries and more broadly across the European Union.

The objective of the project is to explore and develop opportunities for standardized care follow-up models in long-term diseases that impose a significant economic and societal burden. The collaboration will focus on two pilot conditions: Alzheimer’s disease and sleep apnea.

During the project, the partners will assess current care pathways, follow-up structures, data utilization practices, and opportunities to create scalable and internationally applicable models for systematic long-term disease monitoring. The initiative aims to strengthen evidence-based, cost-effective, and patient-centered follow-up practices while supporting the international growth and scalability of StellarQ’s treatment platform services.